# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Meta Materials shares are trading higher by 52.6% during Tuesday's session. The company late Monday announced an update on ...
BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatou...
Meta Materials Inc. (the "Company" or "META") (NASDAQ:MMAT), an advanced materials and nanotechnology company, ...
Meta Materials shares are trading lower by 24% during Monday's session. The company late Friday announced a significant red...